Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to WNT2B" (ENSG00000273483) is a **long non-coding RNA gene** oriented antisense to the WNT2B gene. Natural antisense transcripts like this are widespread in eukaryotic genomes and function mainly to regulate the expression of their corresponding sense genes. Mechanisms include transcriptional interference, RNA masking, formation of double-stranded RNA, and chromatin modification. These processes may impact the transcription, splicing, stability, or translation efficiency of the WNT2B gene, though specific roles of this antisense transcript remain uncharacterized in the literature[1][2][3][4][5]. This transcript is not an established druggable target and has no known direct links to any diseases or drugs. Its regulatory influence exemplifies the complex role of non-coding RNAs in gene expression and epigenetic regulation.
Not applicable for therapeutics. Mechanistically, as a NAT, it may regulate gene expression by: - Transcriptional interference (inhibiting sense transcript) - RNA masking (modifying RNA stability or splicing) - Chromatin remodeling (altering the chromatin state near the sense gene) - Potential RNA interference pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to WNT2B (ENSG00000273483).